ATTI 82° CONGRESSO NAZIONALE SIML Open access

[Bio-hazard in research laboratories]

Authors

Published
25 September 2019
Section
ATTI 82° CONGRESSO NAZIONALE SIML
DOI
10.4081/gimle.523
Pages
359-364

Abstract

Objectives. To deal with biohazards in research laboratories (RL), identify exposure features, types and incidence of laboratory-acquired infections/diseases (LAI), and prevention strategies.
Methods. Literature search and appraisal, non-systematic, last 40 years; legislation, guidelines and good practices evaluation. Results. Biohazards are relevant in RL, in various biomedical, agri-food and industrials sectors, with a variety of LAI (especially viruses and bacteria), modes of exposure and transmission; LAI decrease after preventive measures, vaccinations and clinical treatments; LAl underestimation, due to underreporting and subclinical LAI; need to implement and comply with well-known and available technical and scientific guidelines, good medical and laboratory practices; need for specific health education and training; lack of reporting and epidemiologic surveillance systems, with consequent limited data on risk assessment and effectiveness of preventive interventions. Conclusions. The roles of the occupational physician must be underlined, especially for risk assessment, health and clinicepidemiologic surveillance, with the need to monitor effectiveness of preventive interventions, particularly for biosafety and biosecurity levels in RL. It should be useful to increase capacity of epidemiologic surveillance for LAI, through networking or dedicated websites, in order to collect and analyze accidents, injuries, infections, or adverse events occurred to workers in RL.

References

  1. Alessio L, Porru S, e coll. Linee guida per la sorveglianza sanitaria dei lavoratori della sanità esposti a rischio biologico. In: Linee guida per la formazione continua e l'accreditamento del Medico del Lavoro. Società Italiana di Medicina del Lavoro e Igiene Industriale. Apostoli P, Imbriani M, Soleo L, Abbritti G, Ambrosi L Editori, PIME Editrice, Pavia, 2005.
  2. Autori Vari, Coordinatore S. Porru. Rischio biologico nei lavoratori della sanità. G Ital Med Lav 2010; 32(3): 232-322.
  3. Bienek A, Heisz M, Su M. Surveillance of laboratory exposures to human pathogens and toxins: Canada 2016. Can Comm Dis Rep 2017; 43(11): 228-235. DOI: https://doi.org/10.14745/ccdr.v43i11a04
  4. Coelho AC, Garcia Diez J. Biological risks and laboratory-acquired infections: a reality that cannot be ignored in health biotechnology. Front Bioeng Biotechnol 2015; 3: art. 56. Pp. 1-10. DOI: https://doi.org/10.3389/fbioe.2015.00056
  5. Collins DE, Reuter JD, Rush HG, et al. Viral vector biosafety in laboratory animal research. Comp Med 2017; 67(3): 215-221. Dyson MC, Carpenter CB, Colby LA. Institutional oversight of occupational health and safety for research programs involving biohazards. Comp Med 2017; 67(3): 192-202.
  6. Kimman TG, Smit E, Klein MR. Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures. Clin Microbiol Rev 2008; 21(3): 403-425. DOI: https://doi.org/10.1128/CMR.00014-08
  7. Howard J, Murashov V, Schulte P. Synthetic biology and occupational risk. J Occup Environ Hyg 2017; 14(3): 224-236. DOI: https://doi.org/10.1080/15459624.2016.1237031
  8. Patterson A, Fennington K, Bayha R, et al. Biocontainment laboratory risk assessment: perspectives and considerations. Pathog Dis 2014; 71: 102-108. DOI: https://doi.org/10.1111/2049-632X.12162
  9. Peng H, Bilal M, Iqbal HMN. Improved biosafety and biosecurity measures and/or strategies to tackle laboratory-acquired infections and related risks. Int J Environ Res Pub Health 2018; 15: 2697. DOI: https://doi.org/10.3390/ijerph15122697
  10. Pike RM. Laboratory-associated infections: incidence, fatalities, causes and prevention. Ann Rev Microbiol 1979; 33: 41-66. DOI: https://doi.org/10.1146/annurev.mi.33.100179.000353
  11. Porru S. Risk assessment, health surveillance and fitness for work in health care workers exposed to infectious agents. Working Group Occupational Infectious Agents, International Commission on Occupational Health (ICOH), 2014.
  12. Schlimgen R, Howard J, Wooley D, et al. Risks associated with lentiviral vector exposures and prevention strategies. J Occup Environ Med 2016; 58(12): 1159-1166. DOI: https://doi.org/10.1097/JOM.0000000000000879
  13. Sewell DL. Laboratory-associated infections and biosafety. Clin Microbiol Rev 1995; 8(3): 389-405. DOI: https://doi.org/10.1128/CMR.8.3.389
  14. Singh K. Laboratory-acquired infections. Clinical Infectious Disease 2009; 49: 142-147. DOI: https://doi.org/10.1086/599104
  15. Traxler RM, Lehman MW, Bosserman EA, et al. A literature review of laboratory-acquired brucellosis. J Clin Microbiol 2013; 51(9): 305530662. DOI: https://doi.org/10.1128/JCM.00135-13
  16. Weiss S. Yitzhaki S, Shapira SC. Lessons to be learned from recent biosafety incidents in the United States. IMAJ 2017; 17: 269-273.

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

Copyright (c) 2019 The Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.